Posaconazole Tablets bulk supplier for pharma manufacturers

Posaconazole Tablets Suppliers & Bulk Manufacturers

Available Forms: Delayed-Release Tablets

Available Strengths: 300 mg

Reference Brands: Noxafil(US & EU)

Category: Anti-fungal

Posaconazole delayed-release tablets inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. They provide broad-spectrum antifungal activity, improved absorption, and enhanced bioavailability. Benefits include effective prophylaxis and treatment of invasive fungal infections, with convenient dosing, making them vital for managing severe fungal diseases. Posaconazole Tablets is available in Delayed-Release Tablets and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Posaconazole Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Posaconazole Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Posaconazole delayed-release tablets are approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We facilitate efficient market access for posaconazole delayed-release tablets, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Posaconazole is used to prevent and treat severe fungal infections, especially in patients with weakened immune systems such as those undergoing chemotherapy, stem-cell transplant, or with hematologic malignancies. It is effective against invasive aspergillosis, mucormycosis, and difficult-to-treat Candida infections, and is often chosen when other antifungal therapies are not sufficient or not tolerated.

Posaconazole contains the active triazole antifungal compound posaconazole. It is formulated with pharmaceutical excipients that improve its absorption and ensure consistent systemic exposure for effective antifungal activity.

The primary trade name for posaconazole is Noxafil, widely recognized in the USA, EU, UK, and many other markets.

Noxafil is manufactured by Merck & Co. (MSD). Generic posaconazole is also produced by various GMP-certified pharmaceutical manufacturers around the world.

The generic name is posaconazole.

The main brand name is Noxafil.

Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, and also by multiple approved global GMP manufacturers that produce generic posaconazole for international distribution. 

Yes, Posaconazole Tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Posaconazole Tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Natamycin

Strength:
5%

Form: Ophthalmic Solution

Reference Brands: Natacyn (USA/EU)

View Details
Naftifine Hydrochloride

Strength:
1 %, 2%

Form: Cream / Gel

Reference Brands: Naftin (USA), Xolafin (USA)

View Details
Miltefosine

Strength:
10 mg, 50 mg

Form: Capsules

Reference Brands: Impavido (USA/EU)

View Details
Sertaconazole Nitrate

Strength:
2 %

Form: Creams

Reference Brands: Ertaczo (USA), Zalain (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.